Global Self-Injections Market, By Type (Devices (Needle-Free, Auto, Pen, Wearable Injectors), Formulations), Dosage Form, Therapeutic Application, Route of Administration, End-User, Distribution Channel, Geography (North America, Europe, APAC, MEA, South America) – Trends and Forecast to 2024
Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?chalet=global-self-injections-market-trends-forecast-2024
Global self-injections market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6 % in the forecast period 2017 to 2024.
The global self-injections market is expected to grow exponentially in the forecast period. The exponential growth is owing to multiple factors but the most prominent is development of biologic drugs for the treatment of autoimmune diseases, chronic diseases include heart disease, diabetes, stroke, and chronic respiratory problems.
The self-injections market is segmented based on type, dosage form, and therapeutic application, route of administration, end-user, distribution channel, and geography.
On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.
The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into jet-based, spring-based, laser-powered, and vibration-based. The usability segment is further categorized into reusable and disposable.
The auto-injectors market is segmented into product, technology, design, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into automated and manual. The design segment is further categorized into standardized and customized. The usability segment is further categorized into reusable and disposable.
The pen-injectors market is segmented into product, design, and usability. The product segment is categorized into single-chambered and dual-chambered. The design segment is further categorized into standard and customized.
The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations. The conventional drug delivery segment is categorized into solutions, reconstituted/lyophilized formulations, suspensions and emulsions. The novel drug delivery formulations market is segmented into colloidal dispersions, and microparticles.
Based on therapeutic application, the global self-injections market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose.
On the basis of route of administration, the global self-injections market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.
On the basis of end-user, the global self-injections market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.
Based on geography the global self-injections market is segmented into:
- North America
- South America
- Middle East and Africa
- Rest of the World
The global self-injections market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Some of the major Companies operating in this market are:
- Abbvie, Inc.
- Antares Pharma
- Becton Dickinson & Company
- Baxter International Inc.
- Penjet Corporation
- Pfizer Inc.
- Terumo Corporation
- Mylan N.V.
- SHL Group
- Janssen Biotech Inc.
- Insulet Corporation
- Unilife Corporation
- West Pharmaceutical Services, Inc.
- Eli lilly and Company
- Haselmeier AG
- Credence MedSystems, Inc.
- Owen Mumford Ltd.
- Glide Technologies
Global Pressure Monitoring Devices Market – Industry Trends and Forecast to 2024
Global Pressure Monitoring Devices Market, By Product Type (Blood pressure, Pulmonary Pressure Monitors, Intraocular Pressure Monitors, Intracranial Pressure Monitors, Intracranial Pressure Monitors and Other Pressure Monitoring Devices), By Application (Respiratory Disorders, Glaucoma, Cardiac Disorders, Neurological Disorders, Dialysis), By Procedure (Non-invasive and Invasive), By End User (Hospitals, Ambulatory Surgical Centres and Clinics, Diagnostic Laboratories, Physician), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research